{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T14:37:42Z","timestamp":1794667062358,"version":"4.9.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,11,6]],"date-time":"2017-11-06T00:00:00Z","timestamp":1509926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,11,6]],"date-time":"2017-11-06T00:00:00Z","timestamp":1509926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Claudins are key functional and structural components of tight junctions (TJs) in epithelial cell sheets. The C-terminal fragment of <jats:italic>Clostridium perfringens<\/jats:italic> enterotoxin (C-CPE) binds to claudin-4 and reversibly modulates intestinal TJ seals, thereby enhancing paracellular transport of solutes. However, the use of C-CPE as an absorption enhancer is limited by the molecule\u2019s immunogenicity and manufacturing cost. Here, we developed a high-throughput screening system based on the Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) method to identify claudin-4 binders in a library collection of 32,560 compounds. Thiostrepton, identified from the screen, decreased transepithelial electrical resistance and increased flux of 4-kDa fluorescein isothiocyanate\u2013labelled dextran (FD-4) in Caco-2 cell monolayers, a model of intestinal epithelium. Thiostrepton changed the expression, but not the localisation, of TJ components. Treatment of rat jejunum with thiostrepton increased the absorption of FD-4 without tissue toxicity, indicating that thiostrepton is a novel claudin-4 binder that enhances intestinal permeability. The screening system may therefore be a useful tool for identifying claudin-4 binders to enhance drug absorption in mucosa.<\/jats:p>","DOI":"10.1038\/s41598-017-15108-y","type":"journal-article","created":{"date-parts":[[2017,10,31]],"date-time":"2017-10-31T10:24:55Z","timestamp":1509445495000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Identification of claudin-4 binder that attenuates tight junction barrier function by TR-FRET-based screening assay"],"prefix":"10.1038","volume":"7","author":[{"given":"Akihiro","family":"Watari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Kodaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Matsuhisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kota","family":"Hisaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihito","family":"Kawashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Yamagishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidehiko","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Tsujino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyohito","family":"Yagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masuo","family":"Kondoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,6]]},"reference":[{"key":"15108_CR1","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/nrd1067","volume":"2","author":"M Goldberg","year":"2003","unstructured":"Goldberg, M. & Gomez-Orellana, I. Challenges for the oral delivery of macromolecules. Nat Rev Drug Discov \n                           2, 289\u2013295, https:\/\/doi.org\/10.1038\/nrd1067 (2003).","journal-title":"Nat Rev Drug Discov"},{"key":"15108_CR2","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.addr.2016.06.005","volume":"106","author":"S Maher","year":"2016","unstructured":"Maher, S., Mrsny, R. J. & Brayden, D. J. Intestinal permeation enhancers for oral peptide delivery. Adv Drug Deliv Rev \n                           106, 277\u2013319, https:\/\/doi.org\/10.1016\/j.addr.2016.06.005 (2016).","journal-title":"Adv Drug Deliv Rev"},{"key":"15108_CR3","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1083\/jcb.17.2.375","volume":"17","author":"MG Farquhar","year":"1963","unstructured":"Farquhar, M. G. & Palade, G. E. Junctional complexes in various epithelia. J Cell Biol \n                           17, 375\u2013412 (1963).","journal-title":"J Cell Biol"},{"key":"15108_CR4","first-page":"G467","volume":"269","author":"JM Anderson","year":"1995","unstructured":"Anderson, J. M. & Van Itallie, C. M. Tight junctions and the molecular basis for regulation of paracellular permeability. Am J Physiol \n                           269, G467\u2013475 (1995).","journal-title":"Am J Physiol"},{"key":"15108_CR5","doi-asserted-by":"publisher","first-page":"e24565","DOI":"10.4161\/tisb.24565","volume":"1","author":"C Tscheik","year":"2013","unstructured":"Tscheik, C., Blasig, I. E. & Winkler, L. Trends in drug delivery through tissue barriers containing tight junctions. Tissue Barriers \n                           1, e24565, https:\/\/doi.org\/10.4161\/tisb.24565 (2013).","journal-title":"Tissue Barriers"},{"key":"15108_CR6","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1083\/jcb.136.2.399","volume":"136","author":"V Wong","year":"1997","unstructured":"Wong, V. & Gumbiner, B. M. A synthetic peptide corresponding to the extracellular domain of occludin perturbs the tight junction permeability barrier. J Cell Biol \n                           136, 399\u2013409 (1997).","journal-title":"J Cell Biol"},{"key":"15108_CR7","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1172\/JCI119271","volume":"99","author":"A Fasano","year":"1997","unstructured":"Fasano, A. & Uzzau, S. Modulation of intestinal tight junctions by Zonula occludens toxin permits enteral administration of insulin and other macromolecules in an animal model. J Clin Invest \n                           99, 1158\u20131164, https:\/\/doi.org\/10.1172\/JCI119271 (1997).","journal-title":"J Clin Invest"},{"key":"15108_CR8","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1124\/mol.104.008375","volume":"67","author":"M Kondoh","year":"2005","unstructured":"Kondoh, M. et al. A novel strategy for the enhancement of drug absorption using a claudin modulator. Mol Pharmacol \n                           67, 749\u2013756, https:\/\/doi.org\/10.1124\/mol.104.008375 (2005).","journal-title":"Mol Pharmacol"},{"key":"15108_CR9","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ijpharm.2007.09.011","volume":"351","author":"KH Song","year":"2008","unstructured":"Song, K. H., Fasano, A. & Eddington, N. D. Effect of the six-mer synthetic peptide (AT1002) fragment of zonula occludens toxin on the intestinal absorption of cyclosporin A. Int J Pharm \n                           351, 8\u201314, https:\/\/doi.org\/10.1016\/j.ijpharm.2007.09.011 (2008).","journal-title":"Int J Pharm"},{"key":"15108_CR10","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1021\/mp3000937","volume":"9","author":"D Zwanziger","year":"2012","unstructured":"Zwanziger, D. et al. A peptidomimetic tight junction modulator to improve regional analgesia. Mol Pharm \n                           9, 1785\u20131794, https:\/\/doi.org\/10.1021\/mp3000937 (2012).","journal-title":"Mol Pharm"},{"key":"15108_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2017.05.024","volume":"260","author":"SM Krug","year":"2017","unstructured":"Krug, S. M. et al. Angubindin-1, a novel paracellular absorption enhancer acting at the tricellular tight junction. J Control Release \n                           260, 1\u201311, https:\/\/doi.org\/10.1016\/j.jconrel.2017.05.024 (2017).","journal-title":"J Control Release"},{"key":"15108_CR12","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1124\/jpet.115.225391","volume":"354","author":"M Nakajima","year":"2015","unstructured":"Nakajima, M. et al. Claudin-1 Binder Enhances Epidermal Permeability in a Human Keratinocyte Model. J Pharmacol Exp Ther \n                           354, 440\u2013447, https:\/\/doi.org\/10.1124\/jpet.115.225391 (2015).","journal-title":"J Pharmacol Exp Ther"},{"key":"15108_CR13","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1073\/pnas.96.2.511","volume":"96","author":"K Morita","year":"1999","unstructured":"Morita, K., Furuse, M., Fujimoto, K. & Tsukita, S. Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands. Proc Natl Acad Sci USA \n                           96, 511\u2013516 (1999).","journal-title":"Proc Natl Acad Sci USA"},{"key":"15108_CR14","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1002\/cphy.c110045","volume":"2","author":"D Gunzel","year":"2012","unstructured":"Gunzel, D. & Fromm, M. Claudins and other tight junction proteins. Compr Physiol \n                           2, 1819\u20131852, https:\/\/doi.org\/10.1002\/cphy.c110045 (2012).","journal-title":"Compr Physiol"},{"key":"15108_CR15","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1083\/jcb.147.1.195","volume":"147","author":"N Sonoda","year":"1999","unstructured":"Sonoda, N. et al. Clostridium perfringens enterotoxin fragment removes specific claudins from tight junction strands: Evidence for direct involvement of claudins in tight junction barrier. J Cell Biol \n                           147, 195\u2013204 (1999).","journal-title":"J Cell Biol"},{"key":"15108_CR16","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/j.bcp.2010.01.010","volume":"79","author":"H Uchida","year":"2010","unstructured":"Uchida, H. et al. A claudin-4 modulator enhances the mucosal absorption of a biologically active peptide. Biochem Pharmacol \n                           79, 1437\u20131444, https:\/\/doi.org\/10.1016\/j.bcp.2010.01.010 (2010).","journal-title":"Biochem Pharmacol"},{"key":"15108_CR17","first-page":"543","volume":"66","author":"H Suzuki","year":"2011","unstructured":"Suzuki, H. et al. A toxicological evaluation of a claudin modulator, the C-terminal fragment of Clostridium perfringens enterotoxin, in mice. Pharmazie \n                           66, 543\u2013546 (2011).","journal-title":"Pharmazie"},{"key":"15108_CR18","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.2174\/1389201017666160809164527","volume":"17","author":"E Ergin","year":"2016","unstructured":"Ergin, E., Dogan, A., Parmaksiz, M., Elcin, A. E. & Elcin, Y. M. Time-Resolved Fluorescence Resonance Energy Transfer [TR-FRET] Assays for Biochemical Processes. Curr Pharm Biotechnol \n                           17, 1222\u20131230 (2016).","journal-title":"Curr Pharm Biotechnol"},{"key":"15108_CR19","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1016\/j.bcp.2007.12.016","volume":"75","author":"A Takahashi","year":"2008","unstructured":"Takahashi, A. et al. Domain mapping of a claudin-4 modulator, the C-terminal region of C-terminal fragment of Clostridium perfringens enterotoxin, by site-directed mutagenesis. Biochem Pharmacol \n                           75, 1639\u20131648, https:\/\/doi.org\/10.1016\/j.bcp.2007.12.016 (2008).","journal-title":"Biochem Pharmacol"},{"key":"15108_CR20","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1021\/cr0300441","volume":"105","author":"MC Bagley","year":"2005","unstructured":"Bagley, M. C., Dale, J. W., Merritt, E. A. & Xiong, X. Thiopeptide antibiotics. Chem Rev \n                           105, 685\u2013714, https:\/\/doi.org\/10.1021\/cr0300441 (2005).","journal-title":"Chem Rev"},{"key":"15108_CR21","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.biomaterials.2012.09.051","volume":"34","author":"SM Krug","year":"2013","unstructured":"Krug, S. M. et al. Sodium caprate as an enhancer of macromolecule permeation across tricellular tight junctions of intestinal cells. Biomaterials \n                           34, 275\u2013282, https:\/\/doi.org\/10.1016\/j.biomaterials.2012.09.051 (2013).","journal-title":"Biomaterials"},{"key":"15108_CR22","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1007\/s11095-014-1350-2","volume":"31","author":"I Dittmann","year":"2014","unstructured":"Dittmann, I. et al. Laurate permeabilizes the paracellular pathway for small molecules in the intestinal epithelial cell model HT-29\/B6 via opening the tight junctions by reversible relocation of claudin-5. [Corrected]. Pharm Res \n                           31, 2539\u20132548, https:\/\/doi.org\/10.1007\/s11095-014-1350-2 (2014).","journal-title":"Pharm Res"},{"key":"15108_CR23","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1111\/j.1349-7006.2009.01239.x","volume":"100","author":"M Suzuki","year":"2009","unstructured":"Suzuki, M. et al. Therapeutic antitumor efficacy of monoclonal antibody against Claudin-4 for pancreatic and ovarian cancers. Cancer Sci \n                           100, 1623\u20131630, https:\/\/doi.org\/10.1111\/j.1349-7006.2009.01239.x (2009).","journal-title":"Cancer Sci"},{"key":"15108_CR24","doi-asserted-by":"publisher","first-page":"e00266","DOI":"10.1002\/prp2.266","volume":"4","author":"Y Hashimoto","year":"2016","unstructured":"Hashimoto, Y. et al. Efficacy and safety evaluation of claudin-4-targeted antitumor therapy using a human and mouse cross-reactive monoclonal antibody. Pharmacol Res Perspect \n                           4, e00266, https:\/\/doi.org\/10.1002\/prp2.266 (2016).","journal-title":"Pharmacol Res Perspect"},{"key":"15108_CR25","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1124\/jpet.114.216911","volume":"351","author":"X Li","year":"2014","unstructured":"Li, X. et al. Development of an anti-claudin-3 and -4 bispecific monoclonal antibody for cancer diagnosis and therapy. J Pharmacol Exp Ther \n                           351, 206\u2013213, https:\/\/doi.org\/10.1124\/jpet.114.216911 (2014).","journal-title":"J Pharmacol Exp Ther"},{"key":"15108_CR26","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.neuroscience.2016.04.013","volume":"327","author":"Z Liao","year":"2016","unstructured":"Liao, Z. et al. Specific binding of a mutated fragment of Clostridium perfringens enterotoxin to endothelial claudin-5 and its modulation of cerebral vascular permeability. Neuroscience \n                           327, 53\u201363, https:\/\/doi.org\/10.1016\/j.neuroscience.2016.04.013 (2016).","journal-title":"Neuroscience"},{"key":"15108_CR27","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.bbrc.2011.05.161","volume":"410","author":"A Takahashi","year":"2011","unstructured":"Takahashi, A. et al. Mutated C-terminal fragments of Clostridium perfringens enterotoxin have increased affinity to claudin-4 and reversibly modulate tight junctions in vitro. Biochem Biophys Res Commun \n                           410, 466\u2013470, https:\/\/doi.org\/10.1016\/j.bbrc.2011.05.161 (2011).","journal-title":"Biochem Biophys Res Commun"},{"key":"15108_CR28","doi-asserted-by":"publisher","first-page":"3464","DOI":"10.1016\/j.biomaterials.2012.01.017","volume":"33","author":"A Takahashi","year":"2012","unstructured":"Takahashi, A. et al. Creation and biochemical analysis of a broad-specific claudin binder. Biomaterials \n                           33, 3464\u20133474, https:\/\/doi.org\/10.1016\/j.biomaterials.2012.01.017 (2012).","journal-title":"Biomaterials"},{"key":"15108_CR29","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.3109\/10717544.2015.1050530","volume":"23","author":"T Kojima","year":"2016","unstructured":"Kojima, T. et al. Claudin-binder C-CPE mutants enhance permeability of insulin across human nasal epithelial cells. Drug Deliv \n                           23, 2703\u20132710, https:\/\/doi.org\/10.3109\/10717544.2015.1050530 (2016).","journal-title":"Drug Deliv"},{"key":"15108_CR30","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1093\/jac\/dkn213","volume":"62","author":"G Moulin","year":"2008","unstructured":"Moulin, G. et al. A comparison of antimicrobial usage in human and veterinary medicine in France from 1999 to 2005. J Antimicrob Chemother \n                           62, 617\u2013625, https:\/\/doi.org\/10.1093\/jac\/dkn213 (2008).","journal-title":"J Antimicrob Chemother"},{"key":"15108_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7471","volume":"6","author":"M Buchner","year":"2015","unstructured":"Buchner, M. et al. Identification of FOXM1 as a therapeutic target in B-cell lineage acute lymphoblastic leukaemia. Nat Commun \n                           6, 6471, https:\/\/doi.org\/10.1038\/ncomms7471 (2015).","journal-title":"Nat Commun"},{"key":"15108_CR32","doi-asserted-by":"publisher","first-page":"e39404","DOI":"10.1371\/journal.pone.0039404","volume":"7","author":"K Newick","year":"2012","unstructured":"Newick, K. et al. Peroxiredoxin 3 is a redox-dependent target of thiostrepton in malignant mesothelioma cells. PLoS One \n                           7, e39404, https:\/\/doi.org\/10.1371\/journal.pone.0039404 (2012).","journal-title":"PLoS One"},{"key":"15108_CR33","doi-asserted-by":"publisher","first-page":"e23790","DOI":"10.1371\/journal.pone.0023790","volume":"6","author":"GT Lok","year":"2011","unstructured":"Lok, G. T. et al. Aberrant activation of ERK\/FOXM1 signaling cascade triggers the cell migration\/invasion in ovarian cancer cells. PLoS One \n                           6, e23790, https:\/\/doi.org\/10.1371\/journal.pone.0023790 (2011).","journal-title":"PLoS One"},{"key":"15108_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.155","volume":"6","author":"SY Ju","year":"2015","unstructured":"Ju, S. Y., Huang, C. Y., Huang, W. C. & Su, Y. Identification of thiostrepton as a novel therapeutic agent that targets human colon cancer stem cells. Cell Death Dis \n                           6, e1801, https:\/\/doi.org\/10.1038\/cddis.2015.155 (2015).","journal-title":"Cell Death Dis"},{"key":"15108_CR35","doi-asserted-by":"publisher","first-page":"15042","DOI":"10.1021\/ja0552803","volume":"127","author":"KC Nicolaou","year":"2005","unstructured":"Nicolaou, K. C. et al. Discovery of a biologically active thiostrepton fragment. J Am Chem Soc \n                           127, 15042\u201315044, https:\/\/doi.org\/10.1021\/ja0552803 (2005).","journal-title":"J Am Chem Soc"},{"key":"15108_CR36","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.4161\/cc.7.12.6032","volume":"7","author":"UG Bhat","year":"2008","unstructured":"Bhat, U. G., Zipfel, P. A., Tyler, D. S. & Gartel, A. L. Novel anticancer compounds induce apoptosis in melanoma cells. Cell Cycle \n                           7, 1851\u20131855, https:\/\/doi.org\/10.4161\/cc.7.12.6032 (2008).","journal-title":"Cell Cycle"},{"key":"15108_CR37","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.bcp.2012.01.027","volume":"83","author":"S Qiao","year":"2012","unstructured":"Qiao, S. et al. Thiostrepton is an inducer of oxidative and proteotoxic stress that impairs viability of human melanoma cells but not primary melanocytes. Biochem Pharmacol \n                           83, 1229\u20131240, https:\/\/doi.org\/10.1016\/j.bcp.2012.01.027 (2012).","journal-title":"Biochem Pharmacol"},{"key":"15108_CR38","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1158\/1535-7163.MCT-08-0188","volume":"7","author":"JM Kwok","year":"2008","unstructured":"Kwok, J. M. et al. Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expression. Mol Cancer Ther \n                           7, 2022\u20132032, https:\/\/doi.org\/10.1158\/1535-7163.MCT-08-0188 (2008).","journal-title":"Mol Cancer Ther"},{"key":"15108_CR39","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00424-016-1878-6","volume":"469","author":"Y Hashimoto","year":"2017","unstructured":"Hashimoto, Y., Yagi, K. & Kondoh, M. Roles of the first-generation claudin binder, Clostridium perfringens enterotoxin, in the diagnosis and claudin-targeted treatment of epithelium-derived cancers. Pflugers Arch \n                           469, 45\u201353, https:\/\/doi.org\/10.1007\/s00424-016-1878-6 (2017).","journal-title":"Pflugers Arch"},{"key":"15108_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/srep33632","volume":"6","author":"T Shinoda","year":"2016","unstructured":"Shinoda, T. et al. Structural basis for disruption of claudin assembly in tight junctions by an enterotoxin. Sci Rep \n                           6, 33632, https:\/\/doi.org\/10.1038\/srep33632 (2016).","journal-title":"Sci Rep"},{"key":"15108_CR41","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.13371","author":"H Suzuki","year":"2017","unstructured":"Suzuki, H., Tani, K. & Fujiyoshi, Y. Crystal structures of claudins: insights into their intermolecular interactions. Ann N Y Acad Sci. https:\/\/doi.org\/10.1111\/nyas.13371 (2017).","journal-title":"Ann N Y Acad Sci"},{"key":"15108_CR42","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00424-016-1877-7","volume":"469","author":"M Osanai","year":"2017","unstructured":"Osanai, M., Takasawa, A., Murata, M. & Sawada, N. Claudins in cancer: bench to bedside. Pflugers Arch \n                           469, 55\u201367, https:\/\/doi.org\/10.1007\/s00424-016-1877-7 (2017).","journal-title":"Pflugers Arch"},{"key":"15108_CR43","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1097\/01.LAB.0000078741.55670.6E","volume":"83","author":"H Tamagawa","year":"2003","unstructured":"Tamagawa, H. et al. Characteristics of claudin expression in follicle-associated epithelium of Peyer\u2019s patches: preferential localization of claudin-4 at the apex of the dome region. Lab Invest \n                           83, 1045\u20131053 (2003).","journal-title":"Lab Invest"},{"key":"15108_CR44","doi-asserted-by":"publisher","first-page":"5463","DOI":"10.1016\/j.biomaterials.2010.03.047","volume":"31","author":"H Kakutani","year":"2010","unstructured":"Kakutani, H. et al. Mucosal vaccination using claudin-4-targeting. Biomaterials \n                           31, 5463\u20135471, https:\/\/doi.org\/10.1016\/j.biomaterials.2010.03.047 (2010).","journal-title":"Biomaterials"},{"key":"15108_CR45","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1053\/gast.2001.27124","volume":"121","author":"P Michl","year":"2001","unstructured":"Michl, P. et al. Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin. Gastroenterology \n                           121, 678\u2013684 (2001).","journal-title":"Gastroenterology"},{"key":"15108_CR46","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1517\/14728222.2012.708340","volume":"16","author":"T Kojima","year":"2012","unstructured":"Kojima, T., Kyuno, D. & Sawada, N. Targeting claudin-4 in human pancreatic cancer. Expert Opin Ther Targets \n                           16, 881\u2013887, https:\/\/doi.org\/10.1517\/14728222.2012.708340 (2012).","journal-title":"Expert Opin Ther Targets"},{"key":"15108_CR47","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1158\/1535-7163.MCT-16-0501","volume":"16","author":"E Cocco","year":"2017","unstructured":"Cocco, E. et al. Dual-Targeting Nanoparticles for In Vivo Delivery of Suicide Genes to Chemotherapy-Resistant Ovarian Cancer Cells. Mol Cancer Ther \n                           16, 323\u2013333, https:\/\/doi.org\/10.1158\/1535-7163.MCT-16-0501 (2017).","journal-title":"Mol Cancer Ther"},{"key":"15108_CR48","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.jconrel.2009.10.033","volume":"142","author":"TE Rajapaksa","year":"2010","unstructured":"Rajapaksa, T. E., Stover-Hamer, M., Fernandez, X., Eckelhoefer, H. A. & Lo, D. D. Claudin 4-targeted protein incorporated into PLGA nanoparticles can mediate M cell targeted delivery. J Control Release \n                           142, 196\u2013205, https:\/\/doi.org\/10.1016\/j.jconrel.2009.10.033 (2010).","journal-title":"J Control Release"},{"key":"15108_CR49","doi-asserted-by":"publisher","first-page":"e0126352","DOI":"10.1371\/journal.pone.0126352","volume":"10","author":"H Suzuki","year":"2015","unstructured":"Suzuki, H. et al. C-Terminal Clostridium perfringens Enterotoxin-Mediated Antigen Delivery for Nasal Pneumococcal Vaccine. PLoS One \n                           10, e0126352, https:\/\/doi.org\/10.1371\/journal.pone.0126352 (2015).","journal-title":"PLoS One"},{"key":"15108_CR50","doi-asserted-by":"publisher","first-page":"e0145631","DOI":"10.1371\/journal.pone.0145631","volume":"11","author":"A Watari","year":"2016","unstructured":"Watari, A., Hasegawa, M., Yagi, K. & Kondoh, M. Checkpoint Kinase 1 Activation Enhances Intestinal Epithelial Barrier Function via Regulation of Claudin-5 Expression. PLoS One \n                           11, e0145631, https:\/\/doi.org\/10.1371\/journal.pone.0145631 (2016).","journal-title":"PLoS One"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-15108-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-15108-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-15108-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T13:03:05Z","timestamp":1671800585000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-15108-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,6]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["15108"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-15108-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,6]]},"assertion":[{"value":"21 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"14514"}}